FOLR1 and breast carcinoma: In this study, we generated SmartDC expressing folate receptor alpha antigen (SmartDC-FRα) to activate FRα-specific T lymphocytes and evaluated the cytotoxicity of T lymphocytes activated by SmartDC-FRα against FRα-expressing breast cancer cells.